Investigation of premenstrular dysphoric disorder comorbidity and related factors in patients with anxiety disorder

Investigation of premenstrular dysphoric disorder comorbidity and related factors in patients with anxiety disorder

Aim: Because of the fact that the frequency of both anxiety disorders and premenstrual dysphoric disorder (PMDD) are high in women and that studies investigating PMDD comorbidity in patients diagnosed with anxiety disorder are limited, this study was aimed to investigate PMDD comorbidity and related factors in patients with anxiety disorders. Materials and Methods: 183 subjects who were followed up with a diagnosis of anxiety disorder in Necmettin Erbakan University Meram Medical Faculty Psychiatry Outpatient Clinic were included in the study and were evaluated with Sociodemographic Data Form, Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). PMDD comorbidity was investigated according to The Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV-TR) criteria by making psychiatric interviews. Results: 57 (31.2%) of 183 subjects diagnosed with PMDD constituted the PMDD group and the remaining 126 patients constituted the non-PMDD group. The mean BAI scores of the PMDD group were significantly higher than those of the non PMDD group, whereas the mean age of the PMDD group was significantly lower than that of the non PMDD group. The BMI of the PMDD group was significantly higher than that of the non PMDD group. Conclusion: PMDD is common in patients followed up with a diagnosis of anxiety disorder and what is associated with PMDD is be young age as well as excessive chocolate consumption.

___

  • 1. Dennerstein L, Lehert P, Heinemann K. Epidemiology of premenstrual symptoms and disorders. Menopause Int 2012;18:48-51.
  • 2. Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician 2011;84:918-24.
  • 3. American Psychiatric Assosiation. Diagnostic and Statistical Manual of Mental Disorders Third Edition (DSMIII-R). Washington DC: American Psychiatric Assosiation, 1987.
  • 4. American Psychiatric Assosiation. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV). Washington DC: American Psychiatric Assosiation, 1994.
  • 5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V). Washington DC: American Psychiatric Association; 2013.
  • 6. Miyaoka Y, Akimoto Y, Ueda K, et al. Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. Biopsychosoc Med 2011;2:5:5.
  • 7. Ross LE, Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am 2003;26:529-46.
  • 8. Rapkin AJ, Lewis EI. Treatment of premenstrual dysphoric disorder. Womens Health (Lond) 2013;9:537-56.
  • 9. Steiner M, Li T. Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale. CNS Drugs 2013;27:583-9.
  • 10. Seedhom A, Mohammed E, Mahfouz E. Life style factors associated with premenstrual syndrome among el-minia university students, Egypt. Hindawi Publishing Corporation ISRN PublicHealth, 2013;1-6.
  • 11. 11. Bertone-Johnson ER, Hankinson SE, Willett WC, et al. Adiposity and the development of premenstrual syndrome. J Womens Health (Larchmt) 2010;19:1955- 62.
  • 12. Sepede G, Sarchione F, Matarazzo I, et al. Premenstrual dysphoric disorder without comorbid psychiatric conditions: a systematic review of therapeutic options. Clin Neuropharmacol 2016;39:241-61.
  • 13. Pilver CE, Levy BR, Libby DJ, et al. Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder. Arch Womens Ment Health 2011;14:383-93.
  • 14. Kim D.R, Gyulai L, Freeman E.W, et al. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health 2004;7:37-47.
  • 15. First MB, Spitzer RL, Gibbon M, et al. Structured for DSM-IV Clinical Version (SCID-I/CV) Washington D.C. American Psychiatric Press 1997.
  • 16. Corapcıoglu A, Aydemir O, Yildiz M, et al. DSM-IV Structured Clinical Interview for Axis I Disorders (SCID-I), Clinical Version. In Turkish version: Study of reliability. İlaç ve Tedavi Dergisi (in Turkish) 1999;12:233-6
  • 17. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety. Psychometric properties. J Consult Clin Psychol 1988;56:893-7.
  • 18. Ulusoy M, Erkmen H, Sahin N. Turkish version of the Beck Anxiety Inventory: Psychometric properties. J Cogn Psychother 1998;12:163-72.
  • 19. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961:4:561-71.
  • 20. Hisli N. Validity and reliability of the Beck Depression Inventory for university students. Turk J Psychology 1989;7:3-13.
  • 21. Gunes G, Pehlivan E, Genc M, et al. Premenstruel Syndrome Prevalence in High School Students in Malatya. J Turgut Ozal Medical Center 1997;4:403-6.
  • 22. Muderris I, Gonul AS, Sofuoglu S. Prevalence of Dysphoric Disorder in Young Women. Clinical Psychiatry 1999;2:197-201.
  • 23. Adiguzel H, Taskin EO, Danaci AE. The symptomatology and prevalence of symptoms of premenstrual syndrome in Manisa. Turk J Psychiatry 2007;18:215- 22.
  • 24. Yucel U, Bilge A, Oran N, et al. The prevalence of premenstrual syndrome and its relationship with depression risk in adolescents. Anatolian J Psychiatry 2009;10:55-61.
  • 25. Erbil N, Karaca A, Kiris T. Investigation of premenstrual syndrome and contributing factors among university students. Turk J Med Sci 2010;40:565-73.
  • 26. Tooletto S, Lanzenberger R, Gingnell M, et al. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review. Psychoneuroendocrinology 2014;50,28–52.
  • 27. Polat A, Yucel B. Evaluation of Premenstruel Syndrome in Women with Bipolar Mood Disorder. Noro Psikiyatr Ars 2004;41:5-20.
  • 28. Cırıllo PC, Passos RBF, Bevılaqua MCDN, et al. Bipolar Disorder and Premenstrual Syndrome or Premenstrual Dysphoric Disorder comorbidity: a systematic review. Rev Bras Psiquiatr 2012;34:467-79.
  • 29. Fornaro M, Perugı G. The Impact of Premenstrual Dysphoric Disorder Among 92 Bipolar Patients. Euro Psychiatry 2010;25:450-4.
  • 30. Perıch TA, Roberts G, Frankland A. Clinical characteristics of women with reproductive cycle– associated bipolar disorder symptoms. Aust NZJ Psychiatry 2016;51:161-7.
  • 31. Kamisli O, Kamisli S, Kartalci S, et al. The Evaluation of Premenstrual Dysphoric Disorder Incidence and it’s Relationship with Antiepileptic Drugs in Epilepsy Patients GALE ONEFILE Health and Medicine 2013;19:24-8.
  • 32. Isık H, Ergol S, Aynıoglu O, et al. Premenstrual Syndrome and Life Quality in Turkish Health Science Students. Turk J Med Sci 2016;46:695-701.
  • 33. Halbreich U, O’Brein S, Eriksson E, et al. Are There Differential Symptom Profiles That Improve in Response to Different Pharmacological Treatments of Premenstrual Syndrome/Premenstrual Dysphoric Disorder? CNS Drugs 2006;20:523-47.
  • 34. Treloar SA, Heath AC, Martin NG. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. PsycholMed, 2002;32:25- 38.
  • 35. Kitamura M, Takeda T, Koga S, et al. Relationship Between Premenstrual Symtoms and Dysmenorrhea in Japanese High School Students. Arch Womens Ment Health 2012;15:131-3.
  • 36. Potter JBA, Bouyer J, Trussell J, et al. Premenstrual Syndrome Prevalance and Fluctuation Over Time: Results from a French Population-Based Survey. J Womens Health 2009;18:31-9.
  • 37. Sahin S, Ozdemir K, Unsal A. Evaluation of Premenstrual Syndrome and Quality of Life in University Students. J Pac Med Assoc 2014;64:915-22.
  • 38. Demir B, Algul, YL, Guvendag Guven SE. Investigation of Premenstrual Syndrome Incidence and Affecting Factors in Healthcare Professionals. Turk Soc Obstet Gynecol 2006;3:262-70.
  • 39. Lete I, Duenas LJ, Serrano I, et al. Attitudes of Spanish Women Toward Premenstrual Symptoms, Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Results of A Nationwide Survey. European Journal of Obstetrics & Gynecology and Reproductive Biology 2011;159:115-8.
  • 40. Chayachinda C, Rattanachaiyanont M, Phattharayuttawat S, et al. Premenstrual Syndrome in Thai Nurses. J Psychosomatic Obstetrics & Gynecology 2008;29:199-205.
Annals of Medical Research-Cover
  • Yayın Aralığı: Aylık
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

Lokman Hekim Tanriverdi, Emin Kaya, Mehmet Ali Erkurt, Ahmet Sarici, Ilhami Berber, Omer Faruk Bahcecioglu, Selim Gok, Irfan Kuku

Could the minor autohemotherapy be a complementary therapy for healthcare professionals to prevent COVID-19 infection?

Aydan Orscelik, Murat Parpucu, Ilker Solmaz, Burak Karaaslan, Betul Agiragac

The effects of rosuvastatin and pravastatin on bone metabolism in diabetic rats

Mehmet Tahir Gokdemir, Gul Sahika Gokdemir, Hacer Kayhan, Cihan Gul, Beran Yokus, Ezel Tasdemir, Mukadder Baylan

Sympatho-vagal activity in the mothers of pediatric cancer and non-cancer patients

Sedat Yildiz, Pinar Cakan

Outcomes of vitreoretinal surgery in patients with posterior segment intraocular foreign body

Seyhan Dikci, Turgut Yılmaz

Investigation of premenstrular dysphoric disorder comorbidity and related factors in patients with anxiety disorder

Gokhan Acmaz, Faruk Uguz, Huda Murat Soyak

Preoperative embolization of meningiomas: Single center experience

Bulent Yildiz, Burcak Soylemez

A down syndrome patient diagnosed with transient myeloproliferative disease after presenting with cutaneous findings

Ufuk Cakir, Cuneyt Tayman, Dilek Gurlek Gokcebay, Burak Ceran, Turan Derme, Mehmet Orhan Erkan, Seda Sahin

Analysis of stereotactic biopsies for nonpalpable BIRADS 4 breast lesions: Evaluation of predictors for malignancy

Aydan Eroglu, Serkan Akbulut, Sancar Bayar, Gokhan Avsar, Riza Deryol

A comparison of tetanus antibody levels between patients with high body mass indices and normal patients

Nevin Ince, Attila Onmez, Emel Caliskan